Your session is about to expire
← Back to Search
Behavioral Intervention
Peer-Driven Intervention for HIV Prevention
N/A
Recruiting
Research Sponsored by The Miriam Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age or older
Not currently on PrEP
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-6 months
Awards & highlights
Study Summary
This trial will develop a peer-driven intervention to increase PrEP uptake among men who have sex with men.
Who is the study for?
This trial is for men who have sex with men, are 18 years or older, not currently on PrEP, and speak English or Spanish. They must have been assigned male at birth and still identify as male. Participants should also be sexually active with other men in the past three months.Check my eligibility
What is being tested?
The study aims to develop and test a peer-driven intervention (PDI) strategy to see if it helps increase the use of pre-exposure prophylaxis (PrEP) among men who have sex with men.See study design
What are the potential side effects?
Since this trial focuses on a behavioral intervention rather than a medical treatment, there may not be direct side effects like those associated with drugs; however, participants might experience social or psychological impacts.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am not currently taking medication to prevent HIV.
Select...
I have had sexual relations with men in the past three months.
Select...
I was assigned male at birth and identify as male.
Select...
I speak English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0-6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pre-exposure prophylaxis (PrEP) adherence
Pre-exposure prophylaxis (PrEP) persistence
Pre-exposure prophylaxis (PrEP) uptake
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PDI groupExperimental Treatment1 Intervention
In this group, participants will receive education about HIV and pre-exposure prophylaxis (PrEP) and be referred to our study by peer educators. Referred participants will have free PrEP counseling and receive referrals if interested. We will follow up at three and six months and check participants' PrEP status.
Group II: Control groupActive Control1 Intervention
In the control group, participants do not receive any education from peers and will be directly recruited by research assistants from venues (e.g. gay bars, LGBTQ communities, LGBTQ events, and social media advertisements). Participants will receive PrEP counseling and referral if interested. We will follow up at three and six months and check participants' PrEP status.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer-driven intervention
2010
Completed Phase 2
~600
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,784 Previous Clinical Trials
2,689,075 Total Patients Enrolled
The Miriam HospitalLead Sponsor
238 Previous Clinical Trials
37,275 Total Patients Enrolled
Rhode Island Public Health InstituteUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not currently taking medication to prevent HIV.I am under 18 years old.I have not had sexual relations with men in the last 3 months.I am 18 years old or older.I have had sexual relations with men in the past three months.I was assigned male at birth and identify as male.I speak English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: PDI group
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available for individuals to participate in this experiment?
"Indeed, the information on clinicaltrials.gov attests to this medical trial's search for patients, which began on June 1st 2022 and was revised as recently as August 13th 2022. This experiment hopes to enroll 200 individuals from a single institution."
Answered by AI
How many test subjects are enrolled in this medical experiment?
"Yes, the evidence on clinicaltrials.gov suggests that this medical study is actively recruiting patients at the current moment. The trial was first made available to participants on 6th January 2022 and most recently updated on 13th August 2022; 200 individuals are expected to join from a single trial location."
Answered by AI
What kind of participants is ideal for this research project?
"Patients that meet the criteria of being HIV-positive and between 18 to 100 years old are eligible for this research experiment, which is currently searching for 200 participants."
Answered by AI
Can octogenarians participate in this research study?
"According to the prerequisites, any patient between 18 years old and one century of age is eligible for enrolment in this experiment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger